ERIKA GUNZELMAN: Open Payments
NPI 1821855735 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $116 |
| Janssen Biotech, Inc. | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $38 |
| ABBVIE INC. | 1 | $27 |
Products named: REZDIFFRA, TREMFYA, ENTYVIO, CREON.
Industry payments across MD — which companies pay providers there.
